← back to search

Gordon T. McInnes

University of Glasgow · GB
Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Blood pressure, Spironolactone, Amiloride, Doxazosin, and Bisoprolol.
h-index
citations
1,818
works
4
NIH funding
primary concept
email

Recent publications

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
The Lancet Diabetes & Endocrinology 2018cited by 329position: middledoi
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial
Journal of the American Heart Association 2017cited by 133position: middledoi
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
The Lancet 2015cited by 1,227position: middledoi
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
The Lancet Diabetes & Endocrinology 2015cited by 129position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Sever · Imperial College London3 papers (2015–2017)Ian Ford · University of Glasgow3 papers (2015–2017)Bryan Williams · British Heart Foundation3 papers (2015–2017)Jackie Salsbury · Queen Mary University of London3 papers (2015–2017)Isla S. Mackenzie · University of Dundee3 papers (2015–2017)S. V. Morant · University of Dundee3 papers (2015–2017)Thomas M. MacDonald · Public Safety Canada3 papers (2015–2017)Mark J. Caulfield · Cambridge School3 papers (2015–2017)Morris J. Brown · St Bartholomew's Hospital3 papers (2015–2017)J. CRUICKSHANK · King's College London2 papers (2015–2017)David J. Webb · University of Leicester2 papers (2015–2017)J.K. Cruickshank · King's College London1 papers (2015–2015)